A resurgent coronavirus slowed Coca-Cola’s recovery in the fourth quarter, and the company said the slump has continued into this year. But the Atlanta-based beverage giant said it’s confident it will see improvement as vaccines roll out around the world and it delivers new products in fast-growing categories, like an updated version of Coke Zero Sugar and Topo Chico Hard Seltzer. Coke says it expects 2021 earnings to match or exceed those in 2019. In the fourth quarter, Coke’s net revenue fell 5% to $8.6 billion. Adjusted earnings of 47 cents per share beat Wall Street’s forecast.
